Nanomedicine in cardiovascular therapy: recent advancements

Area of Science:

• Cardiovascular Science
• Nanomedicine
• Biotechnology

Background:

• Cardiovascular disease (CVD) is a major global health concern, with current treatments like stenting and bypass grafting having significant limitations.
• Existing therapies for CVD, including pharmacological and surgical interventions, present challenges such as systemic toxicity, stent thrombosis, and patient ineligibility.
• The limitations of conventional CVD treatments necessitate the exploration of novel therapeutic and diagnostic strategies.

Purpose of the Study:

• To review recent advancements in nanotechnology for cardiovascular disease (CVD).
• To explore the diagnostic and therapeutic potential of nanomedicine in managing CVD.
• To evaluate biocompatible nanomaterials for effective nanobiotechnological tools in CVD applications.

Main Methods:

• Literature review of recent developments in nanotechnology for cardiovascular disease.
• Analysis of biocompatible nanomaterials used in nanomedicine for CVD.
• Evaluation of opportunities and challenges in nanobiotechnological tool development for CVD.

Main Results:

• Nanomedicine presents a promising strategy to address the limitations of current CVD treatments.
• Biocompatible nanomaterials are being explored for diverse applications in CVD diagnostics and therapeutics.
• Nanotechnology offers potential for improved radiological imaging, vascular implants, gene therapy, and targeted drug delivery systems for myocardial infarction.

Conclusions:

• Nanomedicine holds significant promise for advancing cardiovascular disease (CVD) diagnostics and therapeutics.
• Further research into biocompatible nanomaterials and nanobiotechnological tools is crucial for developing effective CVD solutions.
• Nanotechnology offers novel avenues for personalized and targeted treatments in cardiovascular medicine.